⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth
globenewswire.com
TMO
MRK
PFE
NVS
Cutaneous Squamous Cell Carcinoma (cSCC) Market Rises to $8.33 Billion in 2026: Roche, Merck & Co., and Sanofi Leads the Industry
globenewswire.com
MRK
SNY
BMY
NVS
CHKP
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
globenewswire.com
PFE
MRK
SNY
BMY
AZN
NVS
GSK
Paraganglioma Market Trends and Investment Opportunities 2026-2030
globenewswire.com
MRK
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
globenewswire.com
AZN
ABBV
BMY
MRK
Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030
globenewswire.com
PFE
MRK
IDYA
BMY
MDT
Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition
globenewswire.com
JNJ
MRK
IBRX
AZN
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY
Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million
globenewswire.com
PFE
MRK
ABBV
AZN
SNY
Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030
globenewswire.com
PFE
MRK
ABBV
NVS
SNY
BMY
AZN
GSK